Author:
Selvi Poongavanam Senthamil,Behera Archana,Kumar Dharmalingam Jothinathan Mukesh
Reference5 articles.
1. The predictive role of PD-L1 in head and neck cancer: A systematic review and meta-analysis;Paderno;Oral Oncol,2024
2. Immune checkpoint inhibitors efficacy across solid cancers and the utility of PD-L1 as a biomarker of response: a systematic review and meta-analysis;Fitzsimmons;Front Med,2023
3. Biological role of the bidirectional interaction between epithelial-mesenchymal transition and PD-L1 expression in head and neck squamous cell carcinomas: A systematic review;de Farias Morais;Med Oral Patol Oral Cir Bucal,2023
4. Becker, A.S., Zonnur, S., Zimpfer, A., Krause, M., Schneider, B., Strueder, D.F., Burmeister, A.S., Erbersdobler, A., Junghanss, C. and Maletzki, C., 2022. CMTM6 and PD-L1 are independent prognostic biomarkers in head and neck squamous cell carcinoma. Doi: 10.21203/rs.3.rs-2111803/v1.
5. Prognostic Role of PD-L1 Expression in Oral Squamous Cell Carcinoma Varies by Oral Compartments and Immunostaining Patterns: A Meta-analysis;Hua;Authorea Preprints,2023